# VESIcare

NDC: 51248-151
Generic name: solifenacin succinate
Labeler / Manufacturer: Astellas Pharma US, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20050105
Marketing ended: 20260831
FDA application: NDA021518

## Active ingredients

- SOLIFENACIN SUCCINATE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51248-151"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51248-151
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9acee910-cdb2-4052-b8b3-c26aff1c8716